ICAM1 and brain injury: Bhowmick S et al24 have shown that the neural complications caused by traumatic brain injury can be treated by blocking the activation of ICAM-1, so as to reduce the migration of immune cells to the brain, neuroinflammation, and cell death, confirming that ICAM-1 levels correlate with the severity of patients with brain injury.